Delivering on the Promise of Cell and Gene Therapy

175 Forest Street,Waltham MA 02452

21 April, 2022

Description

A city-by-city educational and networking series converging to discuss the inherent challenges and solutions in CGT manufacturing. Manufacturing capacity, complexity and cost are core constraints that limit commercialization of cell and gene therapies (CGT) and ultimately patient access. This event is being presented by leading thought leaders in cell and gene therapy innovation. Germfree is leading a city-by-city educational series on core solutions and considerations for solving the inherent challenges in CGT manufacturing. New innovations in distributed and centralized manufacturing will be presented along with other core topics on how to make commercialization of these therapies a success. This event is being presented by leading thought leaders in cell and gene therapy innovation, and tours of the mobile cleanroom will be provided.